Investing analyses

GTLB GitLab Inc
Sectorother
Mkt cap
Allocation
Statuswatchlist
ScreenMARGINAL 2/6
Atlas2.5/5

atlasHold

2026-04-03 · earnings-review · GitLab delivered a clean beat on Q4 · Conviction 2.5/5

Preview
# GTLB — Q4 FY26 Earnings Review (Atlas)

> Date: 2026-04-03
> Quarter: Q4 FY26 (ended January 31, 2026; reported March 3, 2026)
> Market cap: $3.85B | EV: $2.59B | EV/TTM Rev: 2.7x | Revenue growth: 23.2% YoY

## Verdict

GitLab delivered a clean beat on Q4 (revenue +3.5% vs guide, non-GAAP EPS $0.30 vs $0.23 consensus) but the story is the FY27 guide-down: 15-17% revenue growth, ~500 bps operating margin compression, and EPS of $0.76-$0.80 vs. Street's $1.05. The deceleration is mathematically defensible (300 bps non-recurring tailwinds, ratable model math, DBNR headwind) but represents a structural growth step-down from 26% to mid-teens with no near-term catalyst for reacceleration. The stock at 2.7x EV/TTM revenue is pricing in the worst case. I see a company with legitimate platform positioning in agentic AI, approaching GAAP profitability, with $1.3B cash, zero debt, and 89% non-GAAP gross margins — but needing 2-3 quarters to prove the new management team can execute. Conviction: 2.5/5 — interesting at this valuation but thesis is unproven.

## Qualification Gate

| Criterion | Threshold | Actual | Pass/Fail |
|-----------|-----------|--------|-----------|
| Revenue YoY growth | >30% | 23.2% (Q4), 26% (FY26), guide 16% (FY27) | **FAIL** |
| Gross margin | >60% | 86.6% GAAP / 89.0% Non-GAAP | PASS |
| Revenue per quarter | >$50M | $260.4M | PASS |
| Data availability | 4+ quarters | 16 quarters | PASS |
| Share dilution | <10% annual | 3.8% basic YoY | PASS |
| GAAP profitability trajectory | Improving or positive | Op margin: -9.1% to -2.0% YoY; near breakeven | PASS |

**Gate assessment:** Revenue growth fails the 30% threshold and is decelerating into mid-teens on guidance. This is a $955M revenue company approaching $1B ARR — law of large numbers applies, but the growth profile no longer qualifies as hyper-growth. I proceed with the full analysis because (a) this is a requested earnings review, (b) the valuation is deeply compressed, and (c) there are legi

*…truncated*

wsmStrong

2026-04-08 · earnings-review

Preview
# GTLB — Q4 FY26 Earnings Review (WSM)

**Date:** 2026-04-06
**Quarter:** Q4 FY26 (ended January 31, 2026; reported March 3, 2026)
**Price:** $22.59 | Market Cap: $3.84B | EV: $2.58B | Cash: $1.26B (zero debt)

---

## Verdict

**Growth deceleration into mid-teens is real and the market is pricing it accurately.** Q4 itself was a clean beat — $260.4M revenue (+3.5% vs guide), 20.5% non-GAAP op margin, record $1M+ customer adds. But the FY27 guide of 15-17% growth with 500 bps of margin compression is the thesis-defining data point. At 2.5x EV/run-rate revenue with $1.26B cash and zero debt, the downside is limited — but limited downside is not a thesis. I need to see NRR stabilise, go-to-market ramp deliver bookings growth, and concrete DAP metrics before this becomes actionable.

**Classification: WATCH.** Not a buy, not a sell (because I don't own it). Interesting valuation, but growth trajectory and new management execution are unproven.

---

## The Numbers

### Revenue Grid — QoQ % (Years Across, Quarters Down)

This is the view that matters. Compare each quarter's QoQ to the same quarter in all prior years.

| Quarter | FY23 QoQ | FY24 QoQ | FY25 QoQ | FY26 QoQ | Trend |
|---------|----------|----------|----------|----------|-------|
| Q1 | — | +3.3% | +3.3% | **+1.5%** | **Decelerating** |
| Q2 | +15.6% | +10.0% | +7.9% | **+10.0%** | Rebounded (noise?) |
| Q3 | +11.9% | +7.2% | +7.3% | **+3.6%** | **Decelerating** |
| Q4 | +8.8% | +9.4% | +7.9% | **+6.5%** | **Decelerating** |

Three of four quarters show clear year-over-year QoQ deceleration in FY26. Q2 is the exception — the +10.0% QoQ rebound in FY26 matched FY24 but this looks more like timing than trend. The underlying trajectory is unmistakable: **slowing**.

### Revenue Grid — YoY %

| Quarter | FY24 YoY | FY25 YoY | FY26 YoY | Trend |
|---------|----------|----------|----------|-------|
| Q1 | +45.2% | +33.3% | **+26.8%** | Decelerating |
| Q2 | +38.2% | +30.8% | **+29.2%** | Stable/slight decel |
| 

*…truncated*
Rolling earnings (raw)
# GTLB — Earnings Rolling Summary

> Last updated: 2026-04-03
> Covers: Q1_FY26 → Q4_FY26 (4 quarters)
> Latest ER file: earnings/GTLB/Q4_FY26.md

## Trajectory

Revenue decelerating from 26.8% (Q1 FY26) through 23.2% (Q4 FY26) on a YoY basis, with FY27 guidance stepping down further to 15-17%. The deceleration is driven by: (1) ratable model math as bookings growth has not kept pace with revenue, (2) ~300 bps of non-recurring FY26 tailwinds (price hike, FX, contract clauses), (3) NRR declining from 123% to 118%. Offsetting: enterprise $1M+ customer cohort accelerating (+26% YoY), cRPO growing faster than revenue (24% vs 23%), and DAP launch creating usage-based monetization optionality for FY28. This is a "transition year" story under new management (CEO Dec 2024, CFO Jan 2026).

## Promise Tracker

| Quarter | Promise | Delivered? | Notes |
|---------|---------|-----------|-------|
| Q4_FY26 | FY27 revenue $1,099-$1,118M (15-17%) | Pending | First test: Q1 FY27 guide $253-$255M |
| Q4_FY26 | Highest go-to-market capacity ever; step-function ramp by Q3 FY27 | Pending | Track cRPO and bookings through FY27 |
| Q4_FY26 | NRR to trend down slightly then stabilize in FY27 | Pending | At 118%; expect 115-116% trough |
| Q4_FY26 | DAP material revenue in FY28, not FY27 | Pending | 70% self-managed; 6-month upgrade cycle |
| Q4_FY26 | Non-GAAP GM 85-87% FY27 | Pending | Down from 89% FY26; SaaS/Dedicated/DAP mix |
| Q4_FY26 | $400M buyback program | Pending | No buybacks in Q4; track execution |
| Q4_FY26 | Jehu expenses ~$15M FY27; goal deconsolidation | Pending | Q4 Jehu non-GAAP was $3.9M |

## Language Shift Monitor

| Topic | Q1_FY26 | Q2_FY26 | Q3_FY26 | Q4_FY26 |
|-------|---------|---------|---------|---------|
| Demand | — | — | — | "Record net new ARR quarter"; enterprise strong; US and public sector soft |
| Competition | — | — | — | "Complementary not competitive" with GitHub/CloudCode; security = moat |
| Margins/Efficiency | — | — | — | "Year of stabilization"; deliberate investment; 3 discrete margin drags |
| Product/Innovation | — | — | — | "Generational company"; DAP = orchestration layer; coding agents commoditized |
| AI Narrative | — | — | — | Shifted from "Duo AI features" to "agentic AI platform"; credits-based pricing |

*Note: First rolling file — only Q4 FY26 language captured. Prior quarters not yet populated from transcripts.*

## Analyst Concern Tracker

| Concern | First Raised | Status | Resolution |
|---------|-------------|--------|------------|
| NRR decline trajectory | Q2_FY26 | Active | 123% → 118% over 4Q. CFO guided further decline. No bottom visible yet. |
| FY27 guidance miss vs Street | Q4_FY26 | Active | 15-17% vs ~$1.2B+ implied. 9 analyst PT cuts. "Fourth consecutive quarter guiding below consensus" (Bernstein). |
| Management credibility (4Q below-consensus guides) | Q4_FY26 | Active | New CFO Ross ran investor listening campaign. Transparent guidance build. Trust requires execution. |
| Gross margin compression | Q4_FY26 | Active | GAAP GM 16-quarter low at 86.6%. FY27 guide 85-87% non-GAAP. Mix shift structural. |
| C-suite turnover / cultural risk | Q2_FY26 | Monitoring | CEO, CFO, CPO/CMO, CIO all new within 12 months. Blind reviews negative. |
| Public sector weakness | Q3_FY26 | Monitoring | ~12% ARR; partial recovery only; some business slipped to FY27. |

## Quarter-by-Quarter Verdict

| | Q1_FY26 | Q2_FY26 | Q3_FY26 | Q4_FY26 |
|---|---------|---------|---------|---------|
| Revenue ($m) | $214.5 | $236.0 | $244.4 | $260.4 |
| YoY % | 26.8% | 29.2% | 24.7% | 23.2% |
| Beat % | — | — | — | +3.5% |
| Key Signal | CEO's first full Q | CFO departs to Snowflake | Revenue miss vs Q2 guide | FY27 guide-down; DAP launch |
| Concern | Transition uncertainty | CFO vacancy | Deceleration | 15-17% growth guide; margin compression |
| Positive | Entering $1B ARR range | Strong QoQ add $21.5M | cRPO +22% | cRPO accelerating +24%; $1M+ record; buyback |

## Recent Conferences

| Date | Event | Key Incremental Info |
|------|-------|---------------------|
| — | — | No conference data available yet |

## Source Log

| Date | Persona | What Changed |
|------|---------|-------------|
| 2026-04-03 | atlas | Created rolling file. Populated Q1-Q4 FY26 grid, promise tracker (7 items from Q4 call), language shift (Q4 only), analyst concerns (6 items), quarter verdicts. |
| 2026-04-06 | wsm | Reviewed rolling file. Confirmed NRR decline trajectory matches April 2024 ex-pricing analysis (organic NRR was 118%). Added context: NRR expected trough 115-116%. No structural changes to file — Atlas baseline is accurate. |
FQCalRev (M)YoYGMOp MFCF M
Q4_FY26 Jan-2026 260.4 23.2% 86.6% -2.0% 16.1%
Q3_FY26 Oct-2025 244.4 24.7% 86.8% -5.1%
Q2_FY26 Jul-2025 236.0 29.2% 87.9% -7.8%
Q1_FY26 Apr-2025 214.5 26.8% 88.3% -16.1% 49.1%
Q4_FY25 Jan-2025 211.4 29.1% 89.2% -9.1% 29.4%
Q3_FY25 Oct-2024 196.0 30.9% 88.7% -14.6%
Q2_FY25 Jul-2024 182.6 30.8% 88.3% -22.5%
Q1_FY25 Apr-2024 169.2 33.3% 88.9% -31.7% 22.1%
Q4_FY24 Jan-2024 163.8 33.3% 90.2% -21.3%
Q3_FY24 Oct-2023 149.7 32.5% 89.9% -26.9%
Q2_FY24 Jul-2023 139.6 38.2% 89.5% -38.8%
Q1_FY24 Apr-2023 126.9 45.2% 89.0% -45.9% -8.9%
Q4_FY23 Jan-2023 122.9 88.4% -37.7%
Q3_FY23 Oct-2022 113.0 87.1% -50.4%
Q2_FY23 Jul-2022 101.0 87.1% -64.7%
Q1_FY23 Apr-2022 87.4 88.8% -49.1% -34.4%